Goals

Overarching Goals

  • To enable the development of new and ­effective­ treatments­ and ­medicines­ through innovative products.
  • Continue to establish Genovis products as valuable tools throughout the customer’s value chain from discovery to production of pharmaceuticals.
  • Genovis will create long-term shareholder value through results that generate both dividends for shareholders and funding for innovation and growth initiatives for the continued development of the Company.

Targets 2023-24

Financial Targets

  • Positive EBITDA.
  • Sales growth of 20 percent per year over a three-year period.

Operational Objectives

  • At least three product launches annually.
  • Svenska